Idexx Laboratories — Q1 2024 Earnings Presentation

4 slides from Idexx Laboratories's earnings presentation, May 1, 2024

Slide 1: IDEXX Q1 2024 Earnings Highlights
IDEXX Q1 2024 Earnings Highlights (NASDAQ: (NASDAQ: IDXX) IDXX) Operating Diluted Revenue Profit Earnings Per Share $964M $299M $2.81 Reported growth: +7% 31.0% of Revenue Reported growth: +10% Organic growth: +7% YoY change in basis points: CAG Diagnostics Recurring Reported (10 bps) Comparable gro
Slide 2: 2024 Growth and Financial Performance Outlook
IDEXX Q1 2024 Earnings Highlights (NASDAQ: IDXX) 2024 Growth and Financial Performance Outlook Commentary • Updates 2024 estimates to refine high end of organic growth guidance, incorporate FX impacts from strengthened U.S. dollar and reinforce strong profit performance outlook ◦ Adjusts revenue gui
Slide 3: U.S. Companion Animal Practice Growth Update
+ + + + + + + U.S. Companion Animal Practice Growth Update As of March 31, 2024 Total Practice Revenue and Visit Growth Weighted Average Year-over-Year % Change Per Practice* 20% 16.2% 15% Practice Revenue 10% 7.1% 6.2% 5.7% 6.2% 4.7% 5.3% 4.5% 5% 3.2% 6.2% 0% 2.0% Total Visits 0.8% -0.8% -1.4% -0.8
Slide 4: U.S. Companion Animal Practice Growth Update: Diagnostic Revenue Growth Contributors
+ + + + + + + U.S. Companion Animal Practice Growth Update As of March 31, 2024 Contributors to U.S. Companion Animal Diagnostic Revenue Growth per Practice** Q1’2024 Year-Over-Year Growth (%) + 7.5% + 5.0% 0.0% - 2.5% + 9.0% + 10.0% Q1’2023 + 0.5% + 0.5% + 6.0% + 11.0% Q1 Average 2019-2022 + 1.5% +